Assessment of the metabolic flow phenotype of primary colorectal cancer: Correlations with microvessel density are influenced by the histological scoring method

European Radiology

Volumn 22, Issue 8, 2012, Pages 1687-1692

  Goh, Vicky ^a   Rodriguez Justo, Manuel ^b   Engledow, Alec ^b   Shastry, Manu ^b   Endozo, Raymondo ^b   Peck, Jacqui ^b   Meagher, Marie ^b   Taylor, Stuart A ^b   Halligan, Steve ^b   Groves, Ashley M ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Colon; FDG PET CT; Perfusion CT; Rectum; Tumour

Indexed keywords

ENDOGLIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD FLOW; CHALKLEY ANALYSIS; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; FOUR HOT SPOT ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR VOLUME; TWO HOT SPOT ANALYSIS;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANTIGENS, CD; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM METASTASIS; PERFUSION; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, CELL SURFACE;

EID: 84864680233     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2423-4     Document Type: Article

References (29)

1. Hurwitz H, Fehrenbacher L, Novotny Wet al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
2. Peeters M, Price TJ, Cervantes A et al (2010) Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second line treatment in patients with metastatic colorectal cancer. J Clin Oncol 28:4706-4713
3. Van Cutsem E, Köhne CH, Hitre E et al (2009) Cetuximab and chemotherapy as first line treatment for metastatic colorectal cancer. N Engl J Med 360:1408-1417
4. Jonker DJ, O'Callaghan CJ, Karapetis CS et al (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357:2040-2048
5. Kaira K, Okumura T, Ohde Y et al (2011) Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors. J Nucl Med 52:705-711
6. Kaira K, Endo M, Abe M et al (2011) Biologic correlates of 18FFDG uptake on PET in pulmonary pleomorphic carcinoma. Lung Cancer 71:144-150
7. Kaira K, Endo M, Abe M et al (2010) Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746-3753
8. Groves AM, Shastry M, Rodriguez-Justo M et al (2011) 18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. Eur J Nucl Med Mol Imaging 38:46-52
9. Li Y, Yang ZG, Chen TW et al (2008) Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer 61:44-53
10. Goh V, Halligan S, Daley F et al (2008) Colorectal tumor vascularity: quantitative assessment with multidetector CT-do tumor perfusion measurements reflect angiogenesis? Radiology 249:510-517
11. Chen Y, Zhang J, Dai J, Feng X, Lu H, Zhou C (2010) Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging 35:622-628
12. Yang HF, Du Y, Ni JX et al (2010) Perfusion computed tomography evaluation of angiogenesis in liver cancer. Eur Radiol 20:1424-1430
13. d'Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407-416
14. Yao J, Yang ZG, Chen HJ, Chen TW, Huang J (2011) Gastric adenocarcinoma: can perfusion CT help to noninvasively evaluate tumor angiogenesis? Abdom Imaging 36:15-21
15. Hansen S, Sorensen FB, Vach Wet al (2003) Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 44:428-436
16. Offersen BV, Borre M, Overgaard J (2003) Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 39:881-890
17. Weidner N (1995) Intratumour microvessel density as a prognostic factor in cancer. Am J Pathol 147:9-19
18. Bettencourt M-C, Bauer JJ, Sesterhenn IA et al (1998) CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostatic cancer recurrence after radical prostatectomy. J Urol 160:459-465
19. Dales JP, Garcia S, Andrac L et al (2004) Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-Term patient outcome. Int J Oncol 24:1197-1204
20. Tanaka F, Otake Y, Yanagihara K et al (2001) Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and Anti-CD105 antibody. Clin Cancer Res 7:3410-15
21. Middleton J, Americh L, Gayon R et al (2005) A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: ECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 206:260-268
22. Beliën JA, Somi S, de Jong JS et al (1999) Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 52:184-192
23. Fox SB, Harris AL (2004) Histological quantitation of tumour angiogenesis. APMIS 112:413-430
24. Hansen S, Grabau DA, Sørensen FB et al (2000) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6:139-146
25. Fox SB, Leek RD, Weekes MP et al (1995) Quantification and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J Pathol 177:275-283
26. Vermeulen PB, Gasparini G, Fox SB et al (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564-1579
27. Des Guetz G, Uzzan B, Nicolas P et al (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. meta-Analysis of the literature. Br J Cancer 94:1823-1832
28. Li ZP, Meng QF, Sun CH et al (2005) Tumor angiogenesis and dynamic CT in colorectal carcinoma: radiologic-pathologic correlation. World J Gastroenterol 11:1287-1291
29. Feng ST, Sun CH, Li ZP et al (2010) Evaluation of angiogenesis in colorectal carcinoma with multidetector-row CT multislice perfusion imaging. Eur J Radiol 75:191-196